Abstract:Background Portal vein tumour thrombus (PVTT) in patients with hepatocellular carcinoma (HCC) is known as a major complication associated with poor survival. We clinically defined a new and rare type of HCC, PVTT-type HCC (PVTT-HCC), in a small group of HCC patients with HCC presenting only as PVTT without a demonstrable parenchyma tumour. The clinicopathological and biological features of PVTT-HCC are not clear. Methods The data for patients who had PVTT-HCC with histologically confirmed HCC from January 2004 to December 2012 at the Eastern Hepatobiliary Surgery Hospital were retrospectively analysed. The survival outcomes of patients with PVTT-HCC were compared with those of HCC patients with PVTT (HCC-PVTT). Propensity score matching (PSM) analysis was performed to match patients at a ratio of 1:3. Then, we performed RNA-Seq analysis of liver samples from PVTT-HCC and HCC-PVTT patients to identify and compare differentially expressed genes and biological pathways between the two groups. Results We observed and collected 10 rare cases of PVTT-HCC and performed a prospective cohort study to compare overall survival (OS) between PVTT-HCC and HCC-PVTT. PVTT invaded the main portal vein in 10 PVTT-HCC patients. Univariate and multivariate analyses demonstrated that ChildPugh (A/B), different treatments (LR/non-LR), and different groups were independent risk factors for OS. The median OS was 10.3 months (95% CI = 6.7-13.8) in the HCC-PVTT group and 7.5 months (95% CI = 2.8-12.1) in the PVTT-HCC group (P = 0.042). From RNA-Seq, 1,630 differentially expressed genes were obtained, of which 731 were upregulated and 899 downregulated in PVTT-HCC compared with HCC-PVTT. Conclusions The survival outcomes of patients with PVTT-HCC were worse than those of patients with HCC-PVTT. RNA-Seq demonstrated differential gene expression between PVTT-HCC and HCC-PVTT, indicating that the former may have distinguishing biological characteristics and be a new and rare type of HCC.

A new classification for hepatocellular carcinoma with portal vein tumor thrombus

A New Staging System for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombus

A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus

A new and rare type of hepatocellular carcinoma: survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma

Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.

An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

Prognostic Analysis for Treatment Modalities in Hepatocellular Carcinomas with Portal Vein Tumor Thrombi.

An EHBH-PVTT scoring system as an aid to decision-making on hepatectomy for HCC patients with PVTT: a multicenter study.

Portal Vein Tumor Thrombus is a Bottleneck in the Treatment of Hepatocellular Carcinoma

Multimodality Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

[Progress in Surgical Treatment of Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava].

Hepatocellular carcinoma with tumor thrombi in the portal vein. A comparison of therapeutic effects by different treatments]

Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition).

Updates of diagnosis and differential diagnosis for hepatocellular carcinoma with portal vein tumor thrombus

Surgical Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy

Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients

Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus: a Comparative Study Comparing Hepatectomy with or Without Neoadjuvant Radiotherapy.

Efficacy of Different Treatment Strategies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis